1. Home
  2. YJ vs SNTI Comparison

YJ vs SNTI Comparison

Compare YJ & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yunji Inc. American Depository Shares

YJ

Yunji Inc. American Depository Shares

HOLD

Current Price

$1.85

Market Cap

13.3M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

N/A

Current Price

$0.44

Market Cap

14.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YJ
SNTI
Founded
2015
2016
Country
China
United States
Employees
N/A
39
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3M
14.0M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
YJ
SNTI
Price
$1.85
$0.44
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
2.6M
187.6K
Earning Date
03-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.33
52 Week High
$13.97
$2.88

Technical Indicators

Market Signals
Indicator
YJ
SNTI
Relative Strength Index (RSI) 52.79 39.31
Support Level $1.38 $0.33
Resistance Level $13.97 $1.18
Average True Range (ATR) 1.20 0.04
MACD 0.03 0.03
Stochastic Oscillator 5.59 58.29

Price Performance

Historical Comparison
YJ
SNTI

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China using a membership-based model that leverages the power of social interaction. The group offers high-quality products at attractive prices and incentivizes members to promote its platform and share products with their social contacts. It empowers prime emerging brands and manufacturers with a deep understanding of market trends and customer behavior to produce high-quality products to meet the demands of members. The company also developed several private labels in the mass consumption field, which are sold on its own platform as well as offered and sold through external channels. It operates in the PRC, and substantially all the Group's revenue is derived from within the PRC.

About SNTI Senti Biosciences Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Share on Social Networks: